Skip to main content
. 2005 Nov;64(Suppl 4):iv81–iv85. doi: 10.1136/ard.2005.042721

Figure 1.

Figure 1

 Schematic model of receptor activator of nuclear factor (NF)-κB ligand (RANKL) and tumour necrosis factor α (TNFα) signalling during osteoclastogenesis and inflammation induced bone loss. X, a pathway other than IκB kinase (IKK)/NF-κB that is activated by RANKL binding to RANK and is essential for production of functional osteoclasts. IKKα function in RANK signalling is dispensable. TNFR1, TNF receptor 1.